Our data showed that HACE1 post-transcriptionally upregulated NRF2 expression via an E3 ligase-independent mechanism, and demonstrated that HACE1 promoted malignant behaviors of glioma cells through activating NRF2. The gene discussed is HACE1; the disease is central nervous system cancer.